Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

Degirolamo, Chiara, Sabbà, Carlo, Moschetta, Antonio·2016·Nature Reviews Drug Discovery

DOI 10.1038/nrd.2015.9

Cited by (429)

Items 401–429 of 429

Incorporation of unnatural amino acid into human acidic fibroblast growth factor 1 (FGF1) protein with increased thermal, chemical stability and enhanced bioactivity
Reyhaneh Tavousi Tabatabaei, Zeina Alraawi, Chenguang Fan, Paul Adams, Thallapuranam Krishnaswamy Suresh Kumar · 2025 · Archives of Biochemistry and Biophysics
Plasma proteome mendelian randomization and network pharmacology reveal therapeutic targets for thyroid disorders
Chao Wang, Yi Cai, Xing Yang, Jie Jie · 2026 · Molecular and Cellular Endocrinology
Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver
Jordan M. Beardsley, Michael Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare · 2026 · Molecular Oncology
Rôle des aminoacides ramifiés dans le déterminisme génétique de la résistance à l’insuline
Sara Haydar · 2018 · theses.fr (ABES)
Homéostasie des céramides et hépatopathies métaboliques
Marion Régnier · 2018 · theses.fr (ABES)
Implication de FGF9 et de FGF19 dans la fibrose pulmonaire idiopathique
A. Justet · 2020
Rôle de LECT2 dans les maladies stéatosiques non alcooliques du foie
Sandrine Pham · 2020 · theses.fr (ABES)
Influence du sexe dans la susceptibilité aux hépatopathies métaboliques
Sarra Smati · 2019 · theses.fr (ABES)
Oxford Nanopore sequencing reveals a pervasive role for the mammalian circadian clock in shaping the tissue transcriptome
Lies Chikhaoui · 2022 · theses.fr (ABES)
Rôle des FGFs endocrines et leurs récepteurs au cours de la fibrose pulmonaire idiopathique
Mada Ghanem · 2023 · theses.fr (ABES)
rhFGF21-loaded P hydrogel promoted diabetic wound repair by regulating the inflammatory cytokine expression and phagocytic function of macrophages via the STING-mediated autophagy pathway
Jiana Li, Ruiying Qiu, Shasha Ye, Jingjing Lin, Junyi Wu, YiRan Wang, J P Chen, Yeli Zhao · 2026 · International Immunopharmacology
FGF21 in coronary artery disease: Molecular mechanisms and therapeutic potential
Anchal Thakur, Piyush Chandel, Kanchan Bala · 2026 · Human Gene
Targeting the nuclear factor kappa B pathway for the medical management of intervertebral disc degeneration
Jiansen Wang, Kaixu Han, Dongfeng Li, Yukang Qin, Jing Zhang, Zhinan Ren, Lei Yu, Guangduo Zhu, Cheng Peng, Yingjie Hao · 2026 · Frontiers in Neuroscience
Advances in FGF/FGFR Signaling: Implications for Disease and Therapy
Miaoyu Song, Xi Liu, Yang Xiao, Yongsheng Li, Huakan Zhao · 2026 · MedComm
State-Dependent FGF Signaling in Satellite Cell-Mediated Skeletal Muscle Regeneration and Pathological Remodeling
Shuying Fu, Yuhuan Meng, Keying Liang, Meiying Feng · 2026 · Biomolecules
The Effects of Dietary Fiber and High-Dietary-Fiber Diets on Body Weight Regulation and Lipid Metabolism in Athletes: A Narrative Review
Fuhai FANG, Tingting Hou, Yonglin Chen, Manjiang Hu, Boling Gu, Zhenwei Li, Zhuixin Wang, Yu-Heng Mao · 2026 · Nutrients
Sequencing of Fibroblast Growth Factor Receptor Inhibitors in Cholangiocarcinoma: A Review of Published Cases
Daniel Dilg, Mike Blecker, Ana P. Vivancos, Teresa Mercade Macarulla, Arndt Vogel · 2026 · JCO Precision Oncology
Fibroblast growth factors in Alzheimer’s Disease pathogenesis: neuropharmacological implications for neuroprotection, neurogenesis, and therapeutic development
Jahnvi Sehgal, Kajal Bagri, Rahul Deshmukh · 2026 · Molecular Biology Reports
Circulating fibroblast growth factor 21 predicts adverse outcomes in patients with pre-heart failure and HFpEF
Huiying Li, Yu Bao, Hunan Xiao, Zihui Hu, Juanli Wang, Ping Chen, Yongyi Bai, Wenxiu Leng, Qiwei Zhu, Hongbin Liu · 2026 · Pathology - Research and Practice
Fibroblast Growth Factors and Their Receptors in Major Depressive Disorder: A Scoping Review of Translational Research
Gracja Ryznar, Piotr Gałecki, Katarzyna Bliźniewska-Kowalska · 2026 · International Journal of Molecular Sciences
Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis (MASLD/MASH) and Cardiovascular Risk: Emerging Therapeutic Strategies at the Interface of Liver and Cardiometabolic Disease
Chrysoula Boutari, Konstantinos Charalampidis, Lazaros Sideras, Emmanouil Sinakos, Ioannis Goulis · 2026 · Life
Cancer‐associated fibroblast heterogeneity across solid and haematological malignancies: Lessons from colorectal cancer and multiple myeloma
Hui Mo, Haoyan Han, Michael E O'Dwyer, Eileen Reidy, Aideen E. Ryan · 2026 · The Journal of Physiology
APASL-ACLF without previous decompensation is immunologically distinct from EASL-CLIF-ACLF with previous decompensation
Mona‐May Langer, Marc J. Weiss, Alina Bauschen, Sabrina Guckenbiehl, Gerald Denk, Helena Stadler, Christian M. Lange · 2026 · Frontiers in Immunology
Paracrine fibroblast growth factors in ventricular remodeling after myocardial infarction: mechanisms and therapeutic implications
Bote XU, Qianqian YU, Yisha QIAN, Xu WANG · 2026 · Journal of Zhejiang University (Medical Sciences)
Research progress on the signaling mechanisms of fibroblast growth factor 23 and its targeted drugs
Ruiyi LIU, Sihan Pan, Di WU, Lingfeng CHEN · 2026 · Journal of Zhejiang University (Medical Sciences)
BindingDB Entry 50009178: Fibroblast Growth Factor Receptor 4 (FGFR4) Selective Inhibitors as Hepatocellular Carcinoma Therapy: Advances and Prospects.
BindingDB · 2021 · UC San Diego
BindingDB Entry 50017924: Discovery of 1,6-Naphthyridin-2(1
BindingDB · 2023 · UC San Diego
BindingDB Entry 50019147: Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment.
BindingDB · 2024 · UC San Diego
BindingDB Entry 50049049: 2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors.
BindingDB · 2019 · UC San Diego